GE, R2 get FDA approval for CAD with FFDM

GE Medical Systems of Waukesha, WI, and R2 Technology of Sunnyvale, CA, have received clearance from the Food and Drug Administration to market R2’s ImageChecker CAD technology with GE’s Senographe 2000D full-field digital mammography (FFDM) system.

R2 previously received clearance in 1998 for the use of ImageChecker with digitized mammography films. The companies hope that the combination of CAD with FFDM technology will offer additional benefits to mammography facilities, such as more efficient workflow.

Today nearly 300 Senographe 2000D FFDM systems have been installed in the U.S., and all are upgradeable to R2’s CAD technology, according to GE.

By staff writers
April 19, 2002

Related Reading

GE completes Visualization Technology buy, April 9, 2002

GE OEC debuts 9800 Plus, April 9, 2002

GE sees higher ultrasound revenues, April 3, 2002

R2 expands European activities, March 1, 2002

CAD firm R2 files for IPO, January 2, 2002

Copyright © 2002

Page 1 of 570
Next Page